A Single-Center, Open-Label, Randomized Pilot Study of the Safety and Efficacy of AzaSite Ophthalmic Solution, 1% in Combination With Mechanical Therapy Versus Mechanical Therapy Alone for Four Weeks in Subjects With Posterior Blepharitis.

Trial Profile

A Single-Center, Open-Label, Randomized Pilot Study of the Safety and Efficacy of AzaSite Ophthalmic Solution, 1% in Combination With Mechanical Therapy Versus Mechanical Therapy Alone for Four Weeks in Subjects With Posterior Blepharitis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2011

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Bacterial infections; Blepharitis
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 06 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Oct 2008 Planned end date changed from 1 Sep 2008 to 1 Nov 2008 as reported by CT.gov
    • 01 Oct 2008 Official Title amended as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top